|
|
Volumn 56, Issue 4, 1998, Pages 629-665
|
|
Abciximab. An updated review of its use in ischaemic heart disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
ANTICOAGULATION;
APOPTOSIS;
ARTICLE;
BLEEDING;
CLINICAL TRIAL;
CORONARY ARTERY BLOOD FLOW;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
FEMORAL ARTERY;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
ISCHEMIC HEART DISEASE;
META ANALYSIS;
MIGRATION;
PATIENT SELECTION;
SMOOTH MUSCLE FIBER;
STENT;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOCYTE TRANSFUSION;
THROMBOCYTOPENIA;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
VASCULAR ACCESS;
ANTIBODIES, MONOCLONAL;
ANTICOAGULANTS;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
PLATELET AGGREGATION INHIBITORS;
ANGINA;
|
|
EID: 0031736340
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.2165/00003495-199856040-00014 Document Type: Article |
|
Times cited : (51)
|
|
References (163)
|
